Phase 2 N=176 Video-assisted Thoracoscopic Surgery - Exparel Study
Pain, Postoperative
Primary: Number of Subjects With Post-operative Opioid Usage — 42; 58 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=201 Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies
Non Small Cell Lung Cancer
Primary: Incidence of Intra-Operative Hemostatic Intervention — 0.0533; 0.0833 Proportion transections w/ intervention
Phase 2 N=25 Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
Lung Cancer
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 — 1 Participants
N/A N=50 A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
Non-Small Cell Lung Cancer
Primary: Incidence of Intra-Operative Hemostatic Interventions — 1.8 Percentage of vessel transections
N/A N=105 Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea
Non-small Cell Lung Cancer (NSCLC)
Primary: Occurrence of Prolonged Air Leaks — 0.0; 5.8; 37.5 percentage of participants
N/A N=71 Powered Echelon Device in VATS Surgery
Non-small Cell Lung Cancer (NSCLC)
Primary: Occurrence of Postoperative Air Leaks — 45.8; 67.9; 88.9 percentage of participants
Phase 3 N=147 Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.
Video Assisted Thoracoscopic Surgery · Pain, Postoperative · Pain, Acute
Primary: The Primary Endpoint of This Study Will be VAS Pain Score at 24 Hours — 4.0; 4.5; 3.0 units on a scale
N/A N=216 Comparison of LigaSure to Conventional Electrocoagulation in Video-assisted Thoracoscopic Surgery Lobectomy
Lung Cancer · Complication of Surgical Procedure
Primary: Postoperative Chest Drainage Volume up to Chest Drain Removal, Average 3 Days. — 550; 580 ml
Phase 2 N=110 Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
Esophageal Cancer
Primary: Peri-operative Mortality at 30 Days — 0.029 proportion of participants
N/A N=42 Evaluating Transcutaneous Electrical Nerve Stimulation for Postoperative Pain After Video-Assisted Thoracotomy Surgery
Postoperative Pain
Primary: Mean Pain Score — 4.55; 3.85; 4.30; 3.80 units on a scale
N/A N=170 Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
Head and Neck Cancer · Oropharyngeal Cancer · Hypopharyngeal Cancer
Primary: Number of Participants With Adequate Exposure and Access to Oropharyngeal and Hypopharyngeal Head and Neck Lesions — 147; 23 participants
N/A N=10 Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
Parapneumonic Effusion · Empyema, Pleural · Coagulopathy
Primary: Hospital Length of Stay — 12.4; 8.4 days
N/A N=67 TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR
Right Ventricular Dysfunction
Primary: 3D RVEF (Baseline) — 44.71; 48.74; 49.11 percentage — p=0.0167
N/A N=100 LSA Reconstruction With Laser Fenestration During the TEVAR
Type B Aortic Dissection
Primary: Freedom From All-cause Reintervention, All-cause Mortality and Major Adverse Events Within 30 Days After Procedure — 84 Participants
N/A N=36 The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery
Lung Neoplasms
Primary: Discharge 2weeks Exercise Capacity — 408.61; 311.94 meter(M) — p=<0.05
N/A N=112 Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Pulmonary Disease
Primary: Rate of Device and/or Procedure-related Adverse Events — 42.5 percentage of participants
N/A N=105 Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
Lung Cancer
Primary: Safety Measurement — 0; 0; 0; 0 Adverse events
Phase 3 N=80 Video Double-Lumen Tube Prospective Randomized Study
Other Surgical Procedures
Primary: Number of Participants With Fiberoptic Use During Surgeries Requiring Lung Isolation — 42; 5 Participants — p=<0.0001
N/A N=9 Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
Emphysema
Primary: Count of Patients With Grade 3 or Higher Adverse Events. — 3 Participants
N/A N=490 Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study
Atrial Fibrillation · Pericardial Effusion · Pleural Effusion
Primary: Number of Participants With Postoperative Atrial Fibrillation — 39; 33 Participants
N/A N=50 VivaSight Double Lumen Tube for Single Lung Ventilation
Double Lumen Endotracheal Tube · Single Lung Ventilation
Primary: Number of Participants Requiring Flexible Fiberoptic Bronchoscopy — 25; 7 Participants
N/A N=4 Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization
Morbid Obesity
Primary: Proportion of Procedures Completed With Successful Endoscopic Visualization. — 4 participants
N/A N=40 Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Patients Awaiting Lung Resection
Lung Cancer
Primary: Exercise Tolerance — 459.7; 341 Seconds
Early Phase 1 N=40 Telemedicine in Cardiac Surgery: A Pilot Study
Coronary Artery Disease
Primary: Accuracy (FTF Decision on Patient Disposition vs. V-visit Decision on Patient Disposition) — 89 percentage of agreement
N/A N=80 Comparison of the Effect of Preoperative and Postoperative ESP and PVB on Postoperative Pain in VATS
Anesthesia · Nerve Block · Pain, Postoperative
Primary: Acute Postoperative Pain (With NRS ) — 3.5; 3; 4; 4 NRS score — p=0.365
Phase 3 N=100 To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
Aneurysm, Dissecting · Aortic Aneurysm, Thoracic
Primary: Percentage of Participants With Technically Successful Implant — 99.0 percentage of participants
N/A N=144 HW006 LATERAL Thoracotomy
Left Sided Heart Failure
Primary: Subject is Alive on Original Device, Transplanted, or Explanted for Recovery at 6 Months — 128 Participants — p=0.0003
N/A N=113 Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes
Thoracic Surgery
Primary: Quality of Life at 12 Months — 80.97; 84.02 units on a scale
Phase 3 N=120 Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
Pain, Postoperative · Thoracic · Acute Pain
Primary: The Primary Endpoint of This Study Will be 24 Hours VAS Pain Score at Rest — 4.1; 4.3; 3.3 score on a scale
N/A N=31 Device to Assist With Abdominal Access During Laparoscopic Surgery
Laparoscopic Surgery
Primary: Surgeon Satisfaction Survey — 4; 4; 4; 4 score on a scale